INTRACEPT: Prospective, Randomized, Multi-center Study Intraosseous Basivertebral Nerve Ablation for Treatment of CLBP

NACompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

August 24, 2017

Primary Completion Date

January 18, 2019

Study Completion Date

March 5, 2024

Conditions
Chronic Low Back Pain
Interventions
DEVICE

Intracept System

BVN ablation using radiofrequency energy

OTHER

Standard Care

Non-surgical standard care

Trial Locations (18)

13326

Bassett Medical Center, Cooperstown

14618

University of Rochester, Rochester

17033

Penn State Milton S Hershey Medical Center, Hershey

19147

Temple University, Philadelphia

28207

OrthoCarolina, Charlotte

30060

Drug Studies America, Marietta

30329

Emory University School of Medicine, Atlanta

35235

Alabama Clinical Therapeutics, Birmingham

48073

Beaumont Hospital, Royal Oak

64111

St Luke's Hospital, Kansas City

73013

Clinical Investigations, Edmond

75701

Precision Spine Center, Tyler

80111

Denver Back Specialists, Greenwood Village

85048

Barrow Brain and Spine, Phoenix

90033

Keck Medicine of USC, Los Angeles

94063

Stanford Orthopaedic Surgery, Redwood City

97401

Pacific Sports and Spine, Eugene

03756

Dartmouth Hitchcock Medical Center, Lebanon

All Listed Sponsors
lead

Relievant Medsystems, Inc.

INDUSTRY

NCT03246061 - INTRACEPT: Prospective, Randomized, Multi-center Study Intraosseous Basivertebral Nerve Ablation for Treatment of CLBP | Biotech Hunter | Biotech Hunter